RET and thyroid gland carcinoma: ,99 Alao et al100 investigated the potential of the SPP86 kinase inhibitor as a therapeutic agent for treating thyroid cancer, which selectively inhibited RET-mediated cell proliferation and had no significant effect on RET-unmutated cells.